Scientists dig into old tumor samples to crack the code on rare gland cancers

NCT ID NCT03039439

Summary

This study aims to improve the diagnosis of parathyroid tumors by analyzing stored tissue and blood samples from past patients. Researchers will look for specific markers in the samples to better tell the difference between benign, atypical, and cancerous tumors. The goal is to help doctors make more accurate diagnoses in the future, which could lead to more appropriate and effective treatments.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PRIMARY HYPERPARATHYROIDISM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • M D Anderson Cancer Center

    RECRUITING

    Houston, Texas, 77030, United States

    Contact Phone: •••-•••-••••

    Contact

Conditions

Explore the condition pages connected to this study.